会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
    • 在过敏治疗中被芳氧基烷基基团取代的芳基烷基 - 杂环胺
    • EP0228893A3
    • 1990-01-03
    • EP86310047.5
    • 1986-12-22
    • A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation)
    • Yanni, John MichaelWalsh, David Allan
    • A61K31/445A61K31/47
    • C07D207/08C07D211/14C07D211/18C07D211/22C07D211/70C07D401/06C07D401/12C07D405/06C07D405/12
    • 57 Allergy can be treated with substituted heterocyclic amines, wherein the active agents are expressed generally by the formula:
      wherein p is zero, one or two; m is one to six inclusive; A is selected from hydrogen, hydroxy or cyano; d is zero or one; Q is -CH-, -CH 2 -, or
      n is zero or one and when Q is -CH- and n is one, a douo!e bond is formed with one of the adjacent carbons but not both at the same time, and when n and d are zero at the same time, a double bond is formed between the a carbon and a carbon of the central heterocyclic amine ring Ar, D and R are selected from phenyl, substituted phenyl, pyridinyl, thienyl, furanyl or naphthyl and in addition. R may have the values benzyl, substituted benzyl, cycloalkyl or loweralkyl and D may additionally have the values; 2H-1-benzopyran-2-one, 4-oxo-4H-1-benzopyran-2-carboxylic acid loweralkyl ester, 2,3-dihydro-4N-1-benzopyran-4-one or 1,4-benzodioxan-loweralkyl-2-yl, and the pharmaceutically acceptable salts thereof.
    • 过敏症可以用取代的杂环胺治疗,其中活性剂通常由下式表示:其中p是0,1或2; m是一至六(含); A选自氢,羟基或氰基; d是零或一个; Q是-CH - , - CH 2 - ,或者n是零或1,并且当Q是-CH-并且n是1时,与邻近的碳中的一个形成双键但不同时形成双键,以及 当n和d同时为零时,在中心杂环胺环Ar的碳和碳之间形成双键,D和R选自苯基,取代的苯基,吡啶基,噻吩基,呋喃基或萘基,和 此外。 R可具有苄基,取代的苄基,环烷基或低级烷基值,并且D可另外具有这些值; 2H-1-苯并吡喃-2-酮,4-氧代-4H-1-苯并吡喃-2-羧酸低级烷基酯,2,3-二氢-4N-1-苯并吡喃-4-酮或1,4-苯并二恶烷 - 低级烷基 -2-基及其药学上可接受的盐。